Outcomes in a cohort of women who discontinued maternal triple-antiretroviral regimens initially used to prevent mother-to-child transmission during pregnancy and breastfeeding--Kenya, 2003-2009.

<h4>Background</h4>In 2012, the World Health Organization (WHO) amended their 2010 guidelines for women receiving limited duration, triple-antiretroviral drug regimens during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV (tARV-PMTCT) (Option B) to incl...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Timothy D Minniear, Sonali Girde, Frank Angira, Lisa A Mills, Clement Zeh, Philip J Peters, Rose Masaba, Richard Lando, Timothy K Thomas, Allan W Taylor, Kisumu Breastfeeding Study Team
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2014
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/941c88d079404d06bae63ac7b53cb8c1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Outcomes in a cohort of women who discontinued maternal triple-antiretroviral regimens initially used to prevent mother-to-child transmission during pregnancy and breastfeeding--Kenya, 2003-2009.

Ejemplares similares